Finance Press Releases

October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential

From "Diagnose and Treat" to "Predict, Alert and Intervene"—POMDOCTOR $POM. New AI-Powered Predictive Healthcare Vision Takes Center Stage in October 12 Announcement.

New SmallCapVoice interview with $SKYQ puts the spotlight on a restarted Nevada refinery, 5,000-barrel-per-day potential, a non-dilutive $50 million oil-development initiative and Sky Quarry's plans to ramp both Nevada and Utah operations.

Today's landmark defense contract launches the FDA-approved SPARC-TMS trial while NRx simultaneously advances its preservative-free ketamine program, HOPE Therapeutics and an expanding CNS pipeline

From AI-Powered Chronic Disease Management to "Hardware + AI + Payment," POMDOCTOR Is Building a Broader Digital Healthcare Infrastructure Platform

Today's air-permit approval and immediate Eagle Springs restart mark a major operational milestone, while 5,000-barrel-per-day capacity, 15,000 barrels of crude inventory, Nevada oil-development plans and a tightening Western refining market put Sky...

Cycurion, Inc. (N A S D A Q: CYCU) Expands From Government Cybersecurity Into Public Safety, Healthcare, AI, Fleet Analytics and Commercial Markets as Q2 Margins Surge Nearly 5X and Management Authorizes $500K Share Repurchases

Today's Proposed Combination Could Significantly Expand CDIX's Healthcare Footprint — While New Equity, Warrants and Exercise Activity Put the Capital Structure Squarely in Focus

With a potential Q4 commercial launch, expanding diagnostic opportunities, a major telehealth platform, veterinary oncology initiatives and a proposed Xycota acquisition, NexTel is positioning $MAJI around multiple potential growth catalysts

Today's GeNeuro patent milestone adds a potentially significant ALS opportunity to an already expanding NRx platform, while HOPE Therapeutics advances robotic TMS deployment and the company's preservative-free ketamine program moves closer to...

NRx's HOPE Therapeutics is preparing to deploy Zeta Surgical's newly FDA-cleared robotic TMS technology in Florida, adding another major piece to a rapidly expanding neuropsychiatric platform while the company advances toward potential 2026...

With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S.

With its Nevada refinery preparing to return to production, a potentially transformative $50 million oil-development initiative underway and innovative resource-recovery technology in its portfolio, Sky Quarry $SKYQ is positioning itself for an exciting..

~$30 Million Revenue Run Rate, 800+ New Public-Safety Customers, New Patents and $500,000 Share Repurchase Program Highlight a Dramatic 2026 Transformation

Cycurion, Inc. (NAS DAQ: CYCU) $CYCU Recently Announced a $500,000 Share Repurchase Plan Plus US Patent Protection Extended on Vital Technology for Wide Ranging Security Platforms.

Q2 update reinforces the central NRXP investment thesis: preservative-free ketamine is moving toward commercialization while NRX-101, DARPA funding, HOPE Therapeutics and a stronger balance sheet create multiple potential catalysts.

Affluence Corporation (Stock Symbol: AFFU) $AFFU Delivers AI-Enabled IoT, 5G and Data Visualization Platform;s to Enterprise and Municipal Clients Worldwide

MBody AI Corp / Check-Cap Ltd. (NAS DAQ: MBAI) $MBAI Operates in the $16 Billion 2026 North American Service Robotics Market Projected to Reach $29 Billion by 2031

First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.

Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution

October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential

From "Diagnose and Treat" to "Predict, Alert and Intervene"—POMDOCTOR $POM. New AI-Powered Predictive Healthcare Vision Takes Center Stage in October 12 Announcement.

New SmallCapVoice interview with $SKYQ puts the spotlight on a restarted Nevada refinery, 5,000-barrel-per-day potential, a non-dilutive $50 million oil-development initiative and Sky Quarry's plans to ramp both Nevada and Utah operations.

Today's landmark defense contract launches the FDA-approved SPARC-TMS trial while NRx simultaneously advances its preservative-free ketamine program, HOPE Therapeutics and an expanding CNS pipeline

From AI-Powered Chronic Disease Management to "Hardware + AI + Payment," POMDOCTOR Is Building a Broader Digital Healthcare Infrastructure Platform

New data from LIMRA and Life Happens shows most families buy life insurance to cover final expenses, while more want coverage that helps after a serious health event.

From $GME and $AMC to "Money Never Sleeps," the independent apparel brand is turning market culture, trading terminology and investor identity into wearable fashion.

Today's air-permit approval and immediate Eagle Springs restart mark a major operational milestone, while 5,000-barrel-per-day capacity, 15,000 barrels of crude inventory, Nevada oil-development plans and a tightening Western refining market put Sky...

Cycurion, Inc. (N A S D A Q: CYCU) Expands From Government Cybersecurity Into Public Safety, Healthcare, AI, Fleet Analytics and Commercial Markets as Q2 Margins Surge Nearly 5X and Management Authorizes $500K Share Repurchases

Today's Proposed Combination Could Significantly Expand CDIX's Healthcare Footprint — While New Equity, Warrants and Exercise Activity Put the Capital Structure Squarely in Focus

Mirai RiskTech ("Mirai"), a risk technology company specializing in integrated asset and liability management (ALM) and balance sheet management, has closed a €5 million funding round with Spanish investment firm Inveready.

With a potential Q4 commercial launch, expanding diagnostic opportunities, a major telehealth platform, veterinary oncology initiatives and a proposed Xycota acquisition, NexTel is positioning $MAJI around multiple potential growth catalysts

Today's GeNeuro patent milestone adds a potentially significant ALS opportunity to an already expanding NRx platform, while HOPE Therapeutics advances robotic TMS deployment and the company's preservative-free ketamine program moves closer to...

NRx's HOPE Therapeutics is preparing to deploy Zeta Surgical's newly FDA-cleared robotic TMS technology in Florida, adding another major piece to a rapidly expanding neuropsychiatric platform while the company advances toward potential 2026...

With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S.

With its Nevada refinery preparing to return to production, a potentially transformative $50 million oil-development initiative underway and innovative resource-recovery technology in its portfolio, Sky Quarry $SKYQ is positioning itself for an exciting..

MarketSpeaker delivers financial news, business analysis, and practical guides to help readers understand what moves markets - and what it means for their money.

~$30 Million Revenue Run Rate, 800+ New Public-Safety Customers, New Patents and $500,000 Share Repurchase Program Highlight a Dramatic 2026 Transformation

Buying a stock is only half the decision. Knowing when to sell can be just as important. Selling too soon may limit potential gains, while holding for too long can expose profits to a reversal.

US market leader Kingscrowd launches joint venture with Over Ventures to introduce institutional-grade transparency and data-driven rigor to Europe's fragmented private asset landscape.

Cycurion, Inc. (NAS DAQ: CYCU) $CYCU Recently Announced a $500,000 Share Repurchase Plan Plus US Patent Protection Extended on Vital Technology for Wide Ranging Security Platforms.

Q2 update reinforces the central NRXP investment thesis: preservative-free ketamine is moving toward commercialization while NRX-101, DARPA funding, HOPE Therapeutics and a stronger balance sheet create multiple potential catalysts.

Affluence Corporation (Stock Symbol: AFFU) $AFFU Delivers AI-Enabled IoT, 5G and Data Visualization Platform;s to Enterprise and Municipal Clients Worldwide

MBody AI Corp / Check-Cap Ltd. (NAS DAQ: MBAI) $MBAI Operates in the $16 Billion 2026 North American Service Robotics Market Projected to Reach $29 Billion by 2031

First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.

Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution

If you're looking to generate steady passive income while growing your investment portfolio, high dividend stocks can be an excellent option.

New platform pairs independent editorial content with free calculators and transparently-sourced market data for stocks, crypto, forex, bonds, commodities, and macro.

Leading Innovators in the Emerging AUV/Drone Sector Include ZenaTech (N A S D A Q: ZENA) $ZENA, Draganfly (N A S D A Q: DPRO) $DRPO, Quantum Cyber N.V. (N A S D A Q: QUCY) $QUCY, Unusual Machines, (N YS E American: UMAC) $UMAC, Safe Pro Group Inc.

Record financial performance, expanding European government partnerships, and an integrated technology platform position Circle8 Group $CIRC for its next phase of long-term growth.

With 640% first-quarter revenue growth, a rapidly expanding Drone-as-a-Service platform, strategic acquisitions across North America, AI and quantum computing initiatives, and growing defense opportunities, ZenaTech $ZENA is executing an ambitious...